New York State Common Retirement Fund
APGE icon

New York State Common Retirement Fund’s Apogee Therapeutics APGE Stock Holding History

New York State Common Retirement Fund’s Portfolio APGE Stock Details APGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.11M Sell
15,887
-10,084
-39% -$908K ﹤0.01% 1444
2026
Q1 		$2.19M Buy
25,971
+3,487
+16% +$253K ﹤0.01% 1356
2025
Q4 		$1.7M Buy
22,484
+12,597
+127% +$793K ﹤0.01% 1473
2025
Q3 		$393K Hold
9,887
– – ﹤0.01% 2031
2025
Q2 		$429K Sell
9,887
-2,300
-19% -$87.5K ﹤0.01% 1953
2025
Q1 		$455K Hold
12,187
– – ﹤0.01% 1913
2024
Q4 		$552K Buy
12,187
+1,000
+9% +$51K ﹤0.01% 1913
2024
Q3 		$657K Sell
11,187
-5,200
-32% -$249K ﹤0.01% 1836
2024
Q2 		$645K Sell
16,387
-5,383
-25% -$261K ﹤0.01% 1943
2024
Q1 		$1.45M Buy
21,770
+12,801
+143% +$559K ﹤0.01% 1596
2023
Q4 		$251K Buy
8,969
+4,764
+113% +$95.5K ﹤0.01% 2365
2023
Q3 		$89.6K Buy
+4,205
New +$92.6K ﹤0.01% 2782

Other funds holding APGE

Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CCM
Chicago Capital Management Chicago, Illinois $112M AUM 76.54% 1-Year Est. Return
CIEC
Crédit Industriel et Commercial Paris France, France $1.55B AUM 42.08% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $46.3B AUM 43.9% 1-Year Est. Return
TH
Transmarket Holdings Chicago, Illinois $136M AUM
TMAM
Tokio Marine Asset Management Tokyo, Japan $3.23B AUM 37.2% 1-Year Est. Return
Fifth Third Bancorp
Fifth Third Bancorp Cincinnati, Ohio $61.7B AUM 33.76% 1-Year Est. Return

New York State Common Retirement Fund's APGE Position: Q2 2026 in Review

New York State Common Retirement Fund reduced its Apogee Therapeutics (APGE) stake by 39% in Q2 2026, selling an estimated $908K and leaving 15,887 shares worth $2.11M. The position accounts for ﹤0.01% of the portfolio, ranked #1444.

New York State Common Retirement Fund first reported a position in APGE in Q3 2023 and has held it in 12 quarters since. The position peaked at $2.19M in Q1 2026. 53 funds tracked by Wall St. Rank hold APGE as of Q2 2026.

  • New York State Common Retirement Fund held 15,887 shares of Apogee Therapeutics worth $2.11M as of Q2 2026.
  • New York State Common Retirement Fund sold 10,084 Apogee Therapeutics shares in Q2 2026, an estimated $908K.
  • Apogee Therapeutics made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #1444 holding.
  • New York State Common Retirement Fund first reported a position in Apogee Therapeutics in Q3 2023 and has held it in 12 quarters since.
  • New York State Common Retirement Fund's Apogee Therapeutics position peaked at $2.19M in Q1 2026.
  • 53 funds tracked by Wall St. Rank held Apogee Therapeutics as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.